Overview

Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome

Status:
Completed

Trial end date:
2016-03-01

Target enrollment:
0

Participant gender:
Female

Summary

Efficacy of the use of GnRH antagonist in treatment of those who develop early-onset severe ovarian hyperstimulation syndrome and had cancelled embryo transfer

Phase:

Phase 2

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Ain Shams University

Treatments:

Cetrorelix
Hormone Antagonists
Hormones

Criteria

Inclusion Criteria:

- Women who develop early-onset severe ovarian hyperstimulation syndrome after
controlled ovarian stimulation using long GnRH agonist protocol and hCG for triggering
ovulation.

Exclusion Criteria:

- Women on short or antagonist protocols.

- Women who received GnRH agonist for triggering ovulation.

- Women who had embryo transfer.